Literature DB >> 4007037

Elimination kinetics of thiopentone in mothers and their newborn infants.

F Gaspari, G Marraro, G F Penna, R Valsecchi, M Bonati.   

Abstract

The elimination kinetics of thiopentone was studied in 7 newborns delivered by Caesarean section and in their mothers who had received the drug for induction of anaesthesia. At delivery, 4-9 min after induction, drug concentrations in cord blood were half those in material blood. The mean half-life of thiopentone in the newborns was about double that in their mothers (15 vs 7 h) confirming a disposition similar to other barbiturates. For the first time renal clearance of thiopentone was estimated in the newborn; 0.074 ml/h/kg. Only 0.0007% (about 2 micrograms) of the maternal dose was recovered in the urine of newborns over 36 h. Pentobarbitone, an active metabolite, was not detected in any specimen. The findings demonstrate the reliability of current anaesthesiological technique (thiopentone-succinylcholine-oxygen) with minimal fetal exposure to the drug.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4007037     DOI: 10.1007/bf00543331

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Placental transmission of thiopental.

Authors:  F B McKECHNIE; J G CONVERSE
Journal:  Am J Obstet Gynecol       Date:  1955-09       Impact factor: 8.661

2.  The fate of thiopental in man and a method for its estimation in biological material.

Authors:  B B BRODIE; L C MARK
Journal:  J Pharmacol Exp Ther       Date:  1950-01       Impact factor: 4.030

Review 3.  Developmental aspects of the hepatic cytochrome P450 monooxygenase system.

Authors:  A H Neims; M Warner; P M Loughnan; J V Aranda
Journal:  Annu Rev Pharmacol Toxicol       Date:  1976       Impact factor: 13.820

4.  Pharmacokinetic modelling of thiopental.

Authors:  D R Stanski
Journal:  Anesthesiology       Date:  1981-06       Impact factor: 7.892

5.  Pharmacokinetics and plasma binding of thiopental. I: Studies in surgical patients.

Authors:  D J Morgan; G L Blackman; J D Paull; L J Wolf
Journal:  Anesthesiology       Date:  1981-06       Impact factor: 7.892

6.  Urinary excretion of placentally transferred thiopentone by the human neonate.

Authors:  D J Morgan; C G Beamiss; G L Blackman; J D Paull
Journal:  Dev Pharmacol Ther       Date:  1982

7.  Drug urinary excretion data--some aspects concerning the interpretation.

Authors:  B K Martin
Journal:  Br J Pharmacol Chemother       Date:  1967-02

8.  Determination of optically active thiopental, thiamylal, and their metabolites in human urine.

Authors:  F I Carroll; D Smith; L C Mark; L Brand; J M Perel
Journal:  Drug Metab Dispos       Date:  1977 Jul-Aug       Impact factor: 3.922

9.  Pharmacokinetics of thiopentone: effects of enflurane and nitrous oxide anaesthesia and surgery.

Authors:  M M Ghoneim; M J Van Hamme
Journal:  Br J Anaesth       Date:  1978-12       Impact factor: 9.166

10.  Aortocaval compression and plasma concentrations of thiopentone at caesarean section.

Authors:  D J Morgan; J D Paull; C T Toh; G L Blackman
Journal:  Br J Anaesth       Date:  1984-04       Impact factor: 9.166

View more
  4 in total

Review 1.  Pharmacokinetic/pharmacodynamic modeling of anesthetics in children: therapeutic implications.

Authors:  Jean-Xavier Mazoit
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 2.  Pharmacokinetic optimisation of general anaesthesia in pregnancy.

Authors:  T Gin
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

3.  Placental transfer and tissue distribution of thiopental in the pregnant rat.

Authors:  A Celardo; F Passerini; M Bonati
Journal:  J Pharmacokinet Biopharm       Date:  1989-08

4.  Thiopentone induced coma after severe birth asphyxia.

Authors:  J A Eyre; A R Wilkinson
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.